3D virtual planning software for Fractures, Bone

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Fractures, Bone+1 More
3D virtual planning software - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study the value of 3D virtual planning software in the preoperative planning of tibial plateau fractures.

Eligible Conditions
  • Fractures, Bone
  • Fracture

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Measured at 6 weeks, 3 months and 6 months postoperative

Immediately after x-ray or CT scan is performed
Perioperative deviations
Quality of reduction
Intraoperative
Blood loss
Duration of surgery
Month 6
Postoperative knee function
Postoperative knee pain
Day 30
Surgical complications

Trial Safety

Trial Design

2 Treatment Groups

Conventional planning group
1 of 2
3D virtual planning group
1 of 2
Active Control
Experimental Treatment

70 Total Participants · 2 Treatment Groups

Primary Treatment: 3D virtual planning software · No Placebo Group · N/A

3D virtual planning group
Other
Experimental Group · 1 Intervention: 3D virtual planning software · Intervention Types: Other
Conventional planning groupNoIntervention Group · 1 Intervention: Conventional planning group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: measured at 6 weeks, 3 months and 6 months postoperative

Who is running the clinical trial?

Radboud University Medical CenterLead Sponsor
998 Previous Clinical Trials
510,122 Total Patients Enrolled
4 Trials studying Fractures, Bone
233 Patients Enrolled for Fractures, Bone
Massachusetts General HospitalOTHER
2,673 Previous Clinical Trials
30,828,586 Total Patients Enrolled
14 Trials studying Fractures, Bone
774 Patients Enrolled for Fractures, Bone
Flinders Medical CenterUNKNOWN
Job Doornberg, ProfessorPrincipal InvestigatorUniversity Medical Center Groningen

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: October 26th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.